The impact of extracellular matrix proteins on bovine fibro‐adipogenic progenitor cell adhesion, proliferation, and differentiation in vitro
Physiological Reports · 2025
DOI: 10.14814/phy2.70283 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physiological Reports, 2025. Verfasst von Perri Gish und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurobiology, Physiology, & Behavior, College of Biological Sciences, University of California, Davis, California, USA. Hauptthemen laut MEDLINE: Cell Proliferation, Cell Adhesion, Cell Differentiation, Adipogenesis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, NIGMS NIH HHS, HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).
Abstract (Originalsprache)
Fibro‐adipogenic progenitor cells (FAPs) are mesenchymal stem cells that produce extracellular matrix (ECM) and intramuscular adipocytes in skeletal muscle. While FAPs have demonstrated responsiveness to their physical environment, there is limited knowledge of how the ECM substrate of FAPs impacts their differentiation, particularly in livestock animals. We hypothesized that the ECM substrate FAPs are cultured on will differentially impact their adherence, proliferation, and differentiation. Through an initial screen of 9 ECM proteins and their combinations, significant variation of bovine FAP attachment and differentiation across coatings was observed. The ECM substrates fibronectin, collagen 6, vitronectin, and a combination of fibronectin and collagen 6 were selected for further testing. Notably, fibronectin increased cell proliferation and attachment rates, without impairing FAP adipogenic or fibrogenic differentiation compared to the other coatings. Benefits of fibronectin were maintained at lower concentrations and when combined with less favorable coatings such as collagen 6. When assessed for their adipogenic potential on each coating at different substrate stiffnesses, lipid accumulation decreased with increasing substrate stiffness, while cell attachment increased on stiffer substrates. Overall, these results demonstrate the high responsiveness of FAPs to their ECM substrate, along with highlighting fibronectin as a preferred substrate for in vitro experiments with bovine FAPs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurobiology, Physiology, & Behavior, College of Biological Sciences, University of California, Davis, California, USA.
- Department of Animal Science, College of Agricultural and Environmental Sciences, University of California, Davis, California, USA.
- Department of Physical Medicine and Rehabilitation, School of Medicine, University of California, Davis, California, USA.
ORCID-Profile: Lucas Smith
Förderung
- NIAMS NIH HHS
- NIGMS NIH HHS
- HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- National Science Foundation (NSF)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
Zitieren
APA
Gish, P., Stewart, M., Khuu, B., Meyer, N., Vahmani, P., & Smith, L. (2025). The impact of extracellular matrix proteins on bovine fibro‐adipogenic progenitor cell adhesion, proliferation, and differentiation in vitro. Physiological Reports. https://doi.org/10.14814/phy2.70283
Vancouver
Gish P, Stewart M, Khuu B, Meyer N, Vahmani P, Smith L. The impact of extracellular matrix proteins on bovine fibro‐adipogenic progenitor cell adhesion, proliferation, and differentiation in vitro. Physiological Reports. 2025. doi:10.14814/phy2.70283
BibTeX
@article{Gish2025,
author = {Gish, Perri and Stewart, Madison and Khuu, Brandon and Meyer, Nathaniel and Vahmani, Payam and Smith, Lucas},
title = {The impact of extracellular matrix proteins on bovine fibro‐adipogenic progenitor cell adhesion, proliferation, and differentiation in vitro},
journal = {Physiological Reports},
year = {2025},
doi = {10.14814/phy2.70283}
}
EUVIMED